… of COVID-19, but the functional state of T cells in these patients is not known. Based on the
retrospective study of 522 patients with COVID-19 … 14 patients with COVID-19 and 3 controls. …

… myeloid cell dysregulation, leading to immunopathology and severe disease, and discuss
potential therapeutic strategies targeting myeloid cells as a new paradigm for COVID-19 …

… signature were elevated in mild COVID-19. Severe COVID-19 was marked by occurrence
of … profound alterations in the myeloid cell compartment associated with severe COVID-19. …

… cell compartment, with increased myeloid-… and myeloid cell dysregulation in COVID-19
infection and discuss the potential of MDSCs as biomarkers and therapeutic targets in COVID-19 …

… The six hallmarks are dysregulated type I IFN activity, hyperinflammation, … , dysregulated
myeloid response, and heterogeneous adaptive immunity to SARS-CoV-2. Dysregulation and …

… another myeloid cell subset is significant for the poor prognosis of severe COVID-19 patients…
trajectory of myeloid cells and critical transcription factors in COVID-19 patients provides a …

… ill COVID-19 patients. Our data provides insights into the transient functional dysregulation
of myeloid immune cells against subsequent bacterial infections in COVID-19 patients and …

… myeloid cells are known to be dysregulated in coronavirus … cell RNA sequencing of COVID-19
patient peripheral blood cells … develop a severe form of COVID-19, suggesting a predictive …

… and myeloid compartments in COVID-19 patients. In this study, we used single-cell RNA
sequencing to assess bone marrow mononuclear cells from COVID-19 … of immature myeloid …

… levels of STAT3 phosphorylation in myeloid and lymphocytic cells [… was accompanied by
decreased myeloid cell activation in … pathway for the dysregulation observed in COVID-19 [18]. …